Ranbaxy a wake-up call for Indian pharma

India has been a front runner in the global generic market and has earned a strong reputation as a reliable provider of good quality, affordable treatment options for patients the world over. This one incident of quality and regulatory non-compliance by Ranbaxy has the potential of eroding the high credibility that the Indian pharma industry enjoys. Ranbaxy's failure to take immediate corrective action on the issue of non-compliance added to the gravity of the situation.

Read Full Story>>